InteRNA Technologies

company

About

InteRNA Technologies provides drug discovery and development services.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Information Technology,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment

Nijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors participating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
InteRNA Technologies has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 26, 2013 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 26, 2013 Series Unknown 1 Innovation & Investment Fund Gelderland Detail

Investors

Number of Lead Investors
Number of Investors
1
1
InteRNA Technologies is funded by 1 investors. Innovation & Investment Fund Gelderland are the most recent investors.
Investor Name Lead Investor Funding Round
Innovation & Investment Fund Gelderland Yes Series Unknown